GeoVax Advances Mpox Vaccine Development Amid Rising Global Cases

University of Bristol findings show routine vaccinations are the answer to reducing mpox outbreaks in England.

By Julia Mullins, Co-Editor-in-ChiefResearch conducted by the University of Bristol shows continuing targeted mpox vaccination programme for gay and bisexual men in England will reduce case numbers and save millions for the NHS. Mpox, known previously as monkeypox, is an infectious disease caused by the MPXV virus. You might remember the name from headlines back in 2022 as cases rose in the UK and mpox was declared a global outbreak.   With the …

GeoVax Advances Mpox Vaccine Development Amid Rising Global Cases

GeoVax Labs, Inc., a clinical-stage biotechnology company, is making significant strides in the development of its GEO-MVA vaccine for Mpox and smallpox, addressing the urgent need for diversified vaccine options amidst rising global cases. The company has received favorable regulatory feedback from the European Medicines Agency (EMA), setting the stage for an expedited path toward market access and commercialization. This development is critica…